This study investigated the feasibility of allogeneic (alloSCT) and autologous stem cell
transplantation (ASCT) as postconsolidation therapy for patients with myelodysplastic …

Intensive chemotherapy followed by autologous bone marrow transplantation (ABMT) may
provide an alternative therapy for young patients with myelodysplastic syndrome (MDS) or …

We prospectively assessed autologous stem cell transplantation for consolidation treatment
in a trial of intensive chemotherapy in high risk myelodysplastic syndromes (MDS). In this …

Background Allogeneic stem cell transplantation is usually considered the only curative
treatment option for patients with advanced or transformed myelodysplastic syndromes in …

No standard exists for the treatment of myelodysplastic syndrome relapsing after allogeneic
stem cell transplantation. We performed a retrospective registry analysis of outcomes and …

Hematopoietic cell transplantation is the only curative therapy for patients with
myelodysplastic syndrome (MDS). However, treatment-related toxicity and, in patients with …

To find out prognostic factors and to investigate different therapeutic approaches, we report
on 147 consecutive patients who relapsed after allogeneic hematopoietic stem cell …

We report the results of 65 patients with treatment-related myelodysplastic syndrome
(MDS)/acute myelogenous leukemia (AML) who were transplanted from an autograft and …

BACKGROUND AND OBJECTIVE: There are several therapeutic options for patients with
myeiodysplastic syndrome (MDS) but most of them are poorly effective and the potentially …

Ninety-three patients with myelodysplastic syndrome with either excess blasts or life-
threatening cytopenia received cyclophosphamide and total body irradiation (88 patients) or …